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Figure 4: Molecular Dynamics. Dimeric 3CLpro
homology model shown as green ribbons (Chain 
A), cyan ribbons( Chain B), catalytic dyads are 
shown as green and cyan sticks. Regions found to 
be particularly mobile in 100ns molecular 
dynamics simulations are depicted as magenta 
ribbons. 
10th January, 2020; The first fully sequenced 
genome Wuhan was released to the research 
community 
12th January - Blast, Clustal, EMBOSS 
alignments
– EBI website – all free tools
– Furnished the 3CLpro and PLpro
sequences
13th January - Swissmodel homology 
modelling
– Free tools but “hidden” CC-BY licensing
– Schrödinger model refinement –
academic license not for commercial use
13th-17th January – Desmond molecular 
dynamics – academic licence
17th January – Submit ChemRxiv preprint
• Wait for response from China
• Accepted and posted 25th January
Figure 1: X-ray crystal structure (PDB:2z9j) of 
SARS CoV 3CLpro protease shown as green 
ribbons, with catalytic His41 and Cys145 residues 
shown as cyan sticks. Residues which differ in the 
new SARS-CoV-2  sequence are marked in 
magenta.
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Modelling Pipeline
A regional outbreak of pneumonia in Wuhan, 
Hubei Province of China in late 2019 has 
rapidly evolved into a global pandemic.
The causative agent is a coronavirus, officially 
named SARS-CoV-2, and the disease is now 
designated COVID-19
The outbreak has been accompanied by an 
extraordinarily rapid response from 
researchers worldwide, fuelled by open data 
and dissemination of initial research results on 
free preprint servers, with discussion of results 
taking place on social media, principally 
Twitter as the new default research model.
A key viral enzyme, 3CLpro (also known as 
Main Protease) is an established and 
validated drug target with 17 years of research 
against the related SARS and MERS viruses 
to kick-start the search for an antiviral 
treatment for the new disease.
Introduction
16 Models were built and quality assessed 
using Molprobity
Best were Model 12 (unbound) and Model16 
(ligand-bound)
Major difference between models 12,16 is a 
section of loop Met49 that defines one wall of 
the substrate-binding channel moves 
considerably outward on ligand binding to 
avoid clashed with the Phe2 of the inhibitor.
Results
All Steps except Model refinement 
using free online tools. Final 
Manuscript at ChemRxiv free to 
publish, free to read
Early models of these critical enzymes are 
important starting points for new drug 
discovery
SARS-CoV-2 3CLpro structure very similar to 
the original SARS 3CLpro
Parts of this work have been published in 
preprint on ChemRxiv
https://doi.org/10.26434/chemrxiv.11637294
Conclusions
Figure 2: Homology model of the ligand-bound form of the SARS-CoV-2 3CL protease. Protein depicted in 
monomer form as cyan ribbons with catalytic His41 and Cys145 shown as yellow sticks. The model 
includes a SARS CoV 3CLpro inhibitor shown as grey sticks.
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Figure 3: Overlay of ligand-bound and unbound 
active sites of Wuhan coronavirus 3CLpro. Apo 
Model2 shown as green ribbons, bound Model6 
cyan ribbons. Catalytic triad yellow sticks, SARS 
CoV 3CLpro inhibitor shown as grey sticks.
Models were assessed in dimer and monomer 
forms
100 ns MD in Schrödinger Desmond
Most mobile regions are the surface-exposed 
loops and a -helices. 
N- and C-termini are mobile in monomer form, 
but are stable and buried in the dimer 
interface
Molecular Dynamics
Although the overall SARS-CoV-2 
is most similar to bat 
coronaviruses, the functional 
protease is very similar the SARS 
enzyme
